julos/iStock via Getty Images Investment Thesis UiPath Inc. (NYSE:PATH) is a stock that has been profusely beaten down since its IPO. Further, despite all its narrative over its superior AI bots, its growth prospects have nearly fully fizzled out. However, so, too, have investors' expectations. On the back of its fiscal Q2 2025 earnings results and guidance, as we look out to the next fiscal year starting in 6 months, I estimate that PATH is priced at 20x next year's non-GAAP operating profits. What's more, ...